Data Retention When Subjects Withdraw from FDA-Regulated Clinical Trials: Guidance for Sponsors, Clinical Investigators, and IRBs
Information
Type
Guidance
Regulated products
Biologics, Drugs, Medical Devices
Topics
Good Clinical Practice (GCP)
Published
October 1, 2008
Last updated
July 21, 2021
Description
This document provides guidance on data retention when subjects withdraw from FDA-regulated clinical trials. Topics include Good Clinical Practice (GCP).
Tags
Organization
Country / Region
United States
License
Other (Public Domain)